260 related articles for article (PubMed ID: 22907715)
1. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity.
Abdel-Rahman HM; Ozadali K
Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors.
Eren G; Unlü S; Nuñez MT; Labeaga L; Ledo F; Entrena A; Banoğlu E; Costantino G; Sahin MF
Bioorg Med Chem; 2010 Sep; 18(17):6367-76. PubMed ID: 20692174
[TBL] [Abstract][Full Text] [Related]
3. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
7. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.
Dündar Y; Unlü S; Banoğlu E; Entrena A; Costantino G; Nuñez MT; Labeaga L; Sahin MF; Noyanalpan N
Eur J Med Chem; 2009 May; 44(5):1830-7. PubMed ID: 19084295
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
Handler N; Jaeger W; Kuen-Krismer B; Erker T
Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
Cizmeciolu M; Pabuguoglu V; Ballar P; Pabuççuoğlu A; Soyer Z
Arzneimittelforschung; 2011; 61(3):186-90. PubMed ID: 21528644
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
Unsal-Tan O; Ozadali K; Piskin K; Balkan A
Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
18. Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles.
Vitale P; Perrone MG; Malerba P; Lavecchia A; Scilimati A
Eur J Med Chem; 2014 Mar; 74():606-18. PubMed ID: 24531199
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
Uddin MJ; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
Murias M; Handler N; Erker T; Pleban K; Ecker G; Saiko P; Szekeres T; Jäger W
Bioorg Med Chem; 2004 Nov; 12(21):5571-8. PubMed ID: 15465334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
